Don’t miss the latest developments in business and finance.

Bafna Pharmaceuticals reports standalone net loss of Rs 22.77 crore in the March 2015 quarter

Image
Capital Market
Last Updated : Jun 01 2015 | 12:12 AM IST

Sales decline 50.71% to Rs 19.37 crore

Net Loss of Bafna Pharmaceuticals reported to Rs 22.77 crore in the quarter ended March 2015 as against net loss of Rs 2.01 crore during the previous quarter ended March 2014. Sales declined 50.71% to Rs 19.37 crore in the quarter ended March 2015 as against Rs 39.30 crore during the previous quarter ended March 2014.

For the full year,net profit rose 355.97% to Rs 6.11 crore in the year ended March 2015 as against Rs 1.34 crore during the previous year ended March 2014. Sales declined 42.88% to Rs 101.41 crore in the year ended March 2015 as against Rs 177.54 crore during the previous year ended March 2014.

ParticularsQuarter EndedYear EndedMar. 2015Mar. 2014% Var.Mar. 2015Mar. 2014% Var.Sales19.3739.30 -51 101.41177.54 -43 OPM %-121.1210.23 -25.0011.95 - PBDT-25.740.99 PL 14.0110.55 33 PBT-26.10-2.83 -822 8.772.23 293 NP-22.77-2.01 -1033 6.111.34 356

Powered by Capital Market - Live News

Also Read

First Published: May 30 2015 | 4:16 PM IST

Next Story